source
- Lilly's Foundayo obesity pill posts $98 million Q2 sales, trails Novo's WegovyEli Lilly introduced its oral obesity treatment Foundayo after receiving FDA approval in April 2025. The drug entered the market in the second quarter of 2026, marking Lilly's first foray into an o…
- LifeMine Therapeutics secures $188 million Series E funding from Gates, Bezos and othersLifeMine Therapeutics, a Massachusetts biotech, recently completed a $188 million Series E round, attracting billionaire investors Bill Gates and Jeff Bezos. The funding follows a $75 million Seri…